Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Pearson

Showing results (91-100 of 169) with videos related to

Pageof 17
Sort By:
Health Affairs (Project Hope)|February 6, 2013
Focus groups highlight that many patients object to clinicians' focusing on costsRoseanna Sommers, Susan Dorr Goold, Elizabeth A McGlynn, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|March 29, 2005
Use of an electronic medical record to profile the continuity clinic experiences of primary care residentsThomas D Sequist, Surya Singh, Anne G Pereira, et al.
Journal of Managed Care & Specialty Pharmacy|December 28, 2019
The Effectiveness and Value of Esketamine for the Management of Treatment-Resistant DepressionFoluso Agboola, Steven J Atlas, Daniel R Touchette, et al.
JAMA Network Open|October 22, 2021
Evaluation of the Cost-effectiveness of Drug Treatment for Alzheimer Disease in a Simulation Model That Includes Caregiver and Societal FactorsKouta Ito, Rick Chapman, Steven D Pearson, et al.
Journal of Managed Care & Specialty Pharmacy|July 25, 2022
Oral treatments for outpatient COVID-19: Effectiveness and valueMolly Beinfeld, Kai Yeung, Melanie D Whittington, et al.
Journal of Managed Care & Specialty Pharmacy|May 31, 2021
The effectiveness and value of nadofaragene firadenovec, oportuzumab monatox, and pembrolizumab for BCG-unresponsive non-muscle-invasive bladder cancerMolly Beinfeld, Steven J Atlas, Daniel Touchette, et al.
Health Affairs (Project Hope)|November 11, 2008
Assessing the comparative effectiveness of a diagnostic technology: CT colonographySteven D Pearson, Amy B Knudsen, Roberta W Scherer, et al.
Journal of Managed Care & Specialty Pharmacy|February 28, 2020
The Effectiveness and Value of Siponimod for Secondary Progressive Multiple SclerosisPatricia G Synnott, Lisa M Bloudek, Ravi Sharaf, et al.
Journal of Managed Care & Specialty Pharmacy|August 31, 2021
Anti B-cell maturation antigen CAR T-cell and antibody drug conjugate therapy for heavily pretreated relapsed and refractory multiple myelomaMolly Beinfeld, Sei Lee, Brett McQueen, et al.
Journal of Managed Care & Specialty Pharmacy|August 1, 2024
The impact of capping health system cost savings on the projected cost-effectiveness of etranacogene dezaparvovec compared with factor IX prophylaxis for the treatment of hemophilia BJyotirmoy Sarker, Jeffrey A Tice, David M Rind, et al.
Pageof 17

Showing results (91-100 of 169) with videos related to

Sort By:
Pageof 17
Health Affairs (Project Hope)|February 6, 2013
Focus groups highlight that many patients object to clinicians' focusing on costsRoseanna Sommers, Susan Dorr Goold, Elizabeth A McGlynn, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|March 29, 2005
Use of an electronic medical record to profile the continuity clinic experiences of primary care residentsThomas D Sequist, Surya Singh, Anne G Pereira, et al.
Journal of Managed Care & Specialty Pharmacy|December 28, 2019
The Effectiveness and Value of Esketamine for the Management of Treatment-Resistant DepressionFoluso Agboola, Steven J Atlas, Daniel R Touchette, et al.
JAMA Network Open|October 22, 2021
Evaluation of the Cost-effectiveness of Drug Treatment for Alzheimer Disease in a Simulation Model That Includes Caregiver and Societal FactorsKouta Ito, Rick Chapman, Steven D Pearson, et al.
Journal of Managed Care & Specialty Pharmacy|July 25, 2022
Oral treatments for outpatient COVID-19: Effectiveness and valueMolly Beinfeld, Kai Yeung, Melanie D Whittington, et al.
Journal of Managed Care & Specialty Pharmacy|May 31, 2021
The effectiveness and value of nadofaragene firadenovec, oportuzumab monatox, and pembrolizumab for BCG-unresponsive non-muscle-invasive bladder cancerMolly Beinfeld, Steven J Atlas, Daniel Touchette, et al.
Health Affairs (Project Hope)|November 11, 2008
Assessing the comparative effectiveness of a diagnostic technology: CT colonographySteven D Pearson, Amy B Knudsen, Roberta W Scherer, et al.
Journal of Managed Care & Specialty Pharmacy|February 28, 2020
The Effectiveness and Value of Siponimod for Secondary Progressive Multiple SclerosisPatricia G Synnott, Lisa M Bloudek, Ravi Sharaf, et al.
Journal of Managed Care & Specialty Pharmacy|August 31, 2021
Anti B-cell maturation antigen CAR T-cell and antibody drug conjugate therapy for heavily pretreated relapsed and refractory multiple myelomaMolly Beinfeld, Sei Lee, Brett McQueen, et al.
Journal of Managed Care & Specialty Pharmacy|August 1, 2024
The impact of capping health system cost savings on the projected cost-effectiveness of etranacogene dezaparvovec compared with factor IX prophylaxis for the treatment of hemophilia BJyotirmoy Sarker, Jeffrey A Tice, David M Rind, et al.
Pageof 17